7 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33403775 | Compassionate use of ruxolitinib in patients with SARS-Cov-2 infection not on mechanical ventilation: Short-term effects on inflammation and ventilation. | 2021 May | 1 |
2 | 31654094 | Potent repression of C-reactive protein (CRP) expression by the JAK1/2 inhibitor ruxolitinib in inflammatory human hepatocytes. | 2020 Jan | 6 |
3 | 29508247 | Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies. | 2018 Aug | 1 |
4 | 29675680 | A randomized, double-blind, phase 2 study of ruxolitinib or placebo in combination with capecitabine in patients with advanced HER2-negative breast cancer and elevated C-reactive protein, a marker of systemic inflammation. | 2018 Aug | 1 |
5 | 25441108 | A phase I/II study of the Janus kinase (JAK)1 and 2 inhibitor ruxolitinib in patients with relapsed or refractory acute myeloid leukemia. | 2015 Mar | 2 |
6 | 26351344 | Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed. | 2015 Dec 1 | 1 |
7 | 26463833 | Ruxolitinib Benefits Some with Pancreatic Cancer. | 2015 Dec | 1 |